Dr. Ambinder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8964Fax+1 410-955-0960
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 1979 - 1982
- Johns Hopkins University School of MedicineClass of 1979
- Johns Hopkins UniversityFellowship, Medical Oncology
Certifications & Licensure
- MD State Medical License 1979 - 2026
- VA State Medical License 2023 - 2026
- PA State Medical License 2020 - 2022
- MI State Medical License 1980 - 1982
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Valproic Acid in Treating Patients With Kaposi's Sarcoma Start of enrollment: 2005 Feb 01
- Vaccine Therapy For Patients Being Considered For Organ Transplant Who Are at Risk For PTLD Start of enrollment: 2003 Jan 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsT-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.Michael D. Keller, Sam Darko, Haili Lang, Amy Ransier, Christopher A. Lazarski
British Journal of Haematology. 2019-10-01 - 214 citationsNonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on OutcomeYvette L. Kasamon, Leo Luznik, Mary S. Leffell, Jeanne Kowalski, Hua Ling Tsai
Biology of Blood and Marrow Transplantation. 2010-04-01 - 72 citationsOutcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma.Jennifer A. Kanakry, Yvette L. Kasamon, Christopher D. Gocke, Hua Ling Tsai, Janice Davis-Sproul
Biology of Blood and Marrow Transplantation. 2013-04-01
Abstracts/Posters
- Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 PatientsRichard F. Ambinder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Richard F. Ambinder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase IB Study of Blinatumomab (blina) in Patients with B Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or M...Richard F. Ambinder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Cytomegalovirus Reactivation in Haploidentical Blood or Marrow Transplant (BMT) Using Post-Transplant Cyclophosphamide (PTCy) Is Associated with Higher Non-Relapse-Rel...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 5th Annual T-cell Lymphoma ForumJonathan Wood & Associates, San Francisco, California - 1/24/2013
Other
- Development of malignancy following solid organ transplantationAmbinder RF, Brennan DC, Rodeheffer RJ
http://www.uptodate.com/contents/development-of-malignancy-following-solid-organ-transplantation
UpToDate, Wolters Kluwer Health - 2013-04-18 - The role of Epstein-Barr virus in Hodgkin lymphomaAmbinder RF
http://www.uptodate.com/contents/the-role-of-epstein-barr-virus-in-hodgkin-lymphoma
UpToDate, Wolters Kluwer Health - 2012-06-26 - Systemic therapy for malignancy in patients on anti retroviral medicationsAmbinder RF, Flexner CW, Deeken JF, Rudek MA
http://www.uptodate.com/contents/systemic-therapy-for-malignancy-in-patients-on-anti-retroviral-medi
UpToDate, Wolters Kluwer Health - 2012-08-16
Press Mentions
- Combination Immunotherapy Shows High Activity Against Recurrent Hodgkin LymphomaDecember 3rd, 2018
- HIV-Associated Cancers: A Paradigm Shift?April 19th, 2018
- Liquid Biopsies Study Boosts Cancer Detection HopeAugust 17th, 2017
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/richard-ambinder
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: